Menu
Annual · values2025202420232022202120202019201820172016
Operating Cash Flow-14.51 M USD-3.29 M USD-6.17 M USD-10.23 M USD-9.55 M USD-9.03 M USD-10.34 M USD-9.61 M USD-6.15 M USD-3.20 M USD
Depreciation & Amortization859354 USD205910 USD164306 USD192799 USD145995 USD105382 USD95124 USD69682 USD11415 USD7731 USD
Stock-Based Compensation2.08 M USD874438 USD1.12 M USD1.19 M USD1.10 M USD614302 USD907993 USD814666 USD279508 USD94094 USD
Capital Expenditures1.74 M USD1.36 M USD145816 USD111793 USD326462 USD45752 USD51991 USD126867 USD67002 USD1865 USD
Cash Flow from Investing-7.06 M USD259981 USD-2.03 M USD-310793 USD-326462 USD-45752 USD-51991 USD-126867 USD-67002 USD-1865 USD
Cash Flow from Financing11.43 M USD20.93 M USD9.71 M USD376858 USD13.17 M USD16.78 M USD8.32 M USD3.34 M USD18.38 M USD2.96 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-16.25 M USD-4.65 M USD-6.32 M USD-10.35 M USD-9.87 M USD-9.08 M USD-10.39 M USD-9.73 M USD-6.22 M USD-3.20 M USD

Myomo Inc. is a pioneering company in the field of medical robotics, specializing in the development and production of powered brace systems, specifically for upper-extremity mobility enhancement. These orthotic devices, branded under the name MyoPro, are designed to assist individuals dealing with neuromuscular malfunctions such as those caused by stroke, brachial plexus injury, or other neurological conditions. The primary function of MyoPro is to help users restore functionality and independence in their arms through advanced sensor technology that detects and amplifies the user's own muscle signals. Operating at the intersection of healthcare and technology, Myomo Inc. serves a vital role in the rehabilitation industry, transforming the lives of patients who previously had limited options for recovery. By providing a non-invasive solution to regain strength and mobility, the company's products are significant in addressing a growing need within the healthcare market. Myomo's innovative approach to patient care positions it as an influential player in the medical device sector, contributing to advancements in prosthetics and orthotics.